Company Overview:
Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform with integrated gene editing, delivery and internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.
Position Overview:
Beam is looking for a curious, motivated candidate for its Investor Relations and External Communications Co-op role to join our finance team from July to December 2026. The IR and External Communications Co-op will support Beam's efforts to communicate our mission, science and progress to investors, media and other stakeholders. This role offers hands-on experience assisting with earnings materials, investor presentations, press releases and other external communications content. The co-op will help gather and organize data for our internal IR systems, conduct basic research on peer companies and market trends, and support preparation for investor events. They will collaborate closely with the finance and corporate communications teams to ensure messaging and content is accurate, clear and consistent. This role provides exposure to the biotechnology industry, public company communications, and the intersection of science, finance, and storytelling.
Responsibilities:
Qualifications:
Hourly pay will will be determined based on several factors, including but not limited to, relevant experience, skills, and education.